Our founders have over 60 years of combined experience in global health, clinical trials, and advanced therapeutics manufacturing, our founders have been at the forefront of some of the most groundbreaking innovations in biologics and vaccine development. From developing critical components used in mRNA vaccines during the COVID-19 pandemic to contributing to the first-ever sequencing of the Ebola virus in Africa, their work has shaped the future of global health.
Driven by a shared passion to empower the next generation of scientists, they’ve spent the last year building ABVD – a program designed to demystify vaccine manufacturing and make world-class training accessible, practical, and impactful. This isn’t just another training- it’s the blueprint for transforming biologics manufacturing landscape, one student at a time.
Ready to be part of the future?
Our founders have over 60 years of combined experience in global health, clinical trials, and advanced therapeutics manufacturing, our founders have been at the forefront of some of the most groundbreaking innovations in biologics and vaccine development. From developing critical components used in mRNA vaccines during the COVID-19 pandemic to contributing to the first-ever sequencing of the Ebola virus in Africa, their work has shaped the future of global health.
Driven by a shared passion to empower the next generation of scientists, they’ve spent the last year building ABVD – a program designed to demystify vaccine manufacturing and make world-class training accessible, practical, and impactful. This isn’t just another training- it’s the blueprint for transforming biologics manufacturing landscape, one student at a time.
Ready to be part of the future?
Our founders have over 60 years of combined experience in global health, clinical trials, and advanced therapeutics manufacturing, they’ve been at the forefront of some of the most groundbreaking innovations in biologics and vaccine development. From developing critical components used in mRNA vaccines during the COVID-19 pandemic to contributing to the first-ever sequencing of the Ebola virus in Africa, their work has shaped the future of global health.
Pioneering Africa’s biotech training future—one program, one partnership, one breakthrough at a time.
Engineer Fashola is the founder and CEO of ABVD, a visionary leader with a proven track record in biotechnology and advanced therapy medicinal products. He has a background in developing biotech-focused platforms and designing CMC strategies for mRNA vaccines and therapies, protein synthesis, and cell & gene therapy, Engineer Fashola is committed to building Africa’s capacity to lead in vaccine and biologics production.
Engineer Fashola was instrumental in the plight to design and scale up critical materials used in Covid-19 Vaccines and the Therapy used to mitigate Sickle Cell.
Highlights:
Driving biotech innovation and clinical research leadership across Africa.
Dr. Salami is a seasoned biotech entrepreneur and clinical research leader with 15+ years of global experience in drug development, infectious diseases, and regulatory strategy. He has led major trials with FIND Diagnostics, DNDi, and SGS Health Science, and collaborated with WHO and Oxford University. At ABVD, he is focused on expanding Africa’s biotech infrastructure and championing high-quality, locally driven therapeutics and diagnostics.
Highlights:
Bringing scientific expertise and hands-on innovation to vaccine development.
Dr. James is a molecular biology expert with extensive experience in qPCR, sequencing, diagnostics, and life science instrumentation. He played a vital role in the Ebola response in Nigeria and has trained professionals on cutting-edge lab technologies. At ABVD, he leads the design and delivery of our technical programs, ensuring our training remains world-class and highly relevant.
Highlights:
Championing ethical clinical research and sustainable health systems.
Titus brings decades of leadership in clinical research governance, data systems, and regulatory frameworks. With deep expertise in biochemistry, epidemiology, and healthcare operations, he ensures ABVD’s programs are ethically sound, scalable, and aligned with global standards—while grounded in Africa’s unique public health needs.
Highlights:
Interested in advancing your expertise in malaria mRNA vaccine development ?
Join our 5-Day Intensive Training on Malaria mRNA Vaccine Development.
Register now through the link below or visit our homepage and sign up under Account section.
Selected candidates will be contacted by ABVD with next steps.
Registration closes November 26, 2025- don’t miss your chance to be part of this groundbreaking initiative!
Free all Expenses Paid for (transportation, meals, accommodation, and training)
